2022 Annual Meeting | P12 - Poster Session 12

Date Tuesday 04/05/22

Time 05:30 PM - 06:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Education, Research, and Methodology, Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-oncology

CME Available 0.00 CME credit

Program Materials Program Evaluations

Event Timeline
05:30 PM - 06:30 PM PDT	Abstract	9-001 - Acute Hemorrhagic Leukoencephalitis as a Primary Presentation in an Immunocompromised Patient With Cerebral Toxoplasmosis Sukriye Damla Kara, MD
05:30 PM - 06:30 PM PDT	Abstract	9-002 - A case report of Granulomatous angiitis associated with Cogan syndrome. Praveen Ramani, MBBS
05:30 PM - 06:30 PM PDT	Abstract	9-003 - HSV-2 Encephalitis Presenting with Immune-Responsive Chorea Michael D. Kolesnik, DO
05:30 PM - 06:30 PM PDT	Abstract	9-004 - NMDAR-Antibody Encephalitis Presenting with Faciobrachial Dystonic Seizues in a Gravid Nigerian Woman Fatima I. Abdulai, MBBS
05:30 PM - 06:30 PM PDT	Abstract	9-006 - Spectrum of Combined Central and Peripheral Demyelination: A Case Report Sukriye Damla Kara, MD
05:30 PM - 06:30 PM PDT	Abstract	9-007 - Pediatric AMPA Receptor Encephalitis (AMPARE): A Case Report and Literature Review Alexandra Sankovic, MD
05:30 PM - 06:30 PM PDT	Abstract	15-001 - Real-World Effectiveness of Ubrogepant Among Participants With Prior Treatment Failure: Subgroup Analysis From the UNIVERSE Study Krutika Jariwala-Parikh, PhD
05:30 PM - 06:30 PM PDT	Abstract	15-002 - Reductions in Migraine-related Health Care Resource Utilization and Costs for Patients Initiating Fremanezumab: Results of a Long-term US Claims Database Analysis
05:30 PM - 06:30 PM PDT	Abstract	15-003 - Reduction in Period Prevalence of Medication Overuse Headache Following Initiation of Nurtec ODT Treatment – A Real World Administrative Claims Study Ali Mohajer, PhD
05:30 PM - 06:30 PM PDT	Abstract	15-004 - Early Prediction of Response to INP104 for the Acute Treatment of Migraine Sara E. Sacco, MD
05:30 PM - 06:30 PM PDT	Abstract	15-005 - Efficacy and Safety of Subcutaneous Sumatriptan for Acute Migraine Attacks Compared with other treatments: A Systematic Review and Network Meta-analysis. Mohamed S. Zaazouee
05:30 PM - 06:30 PM PDT	Abstract	3-001 - Functional Connectivity Rearrangements Propagating from Disease Epicenters in Frontotemporal Lobar Degeneration Variants Edoardo G. Spinelli, MD
05:30 PM - 06:30 PM PDT	Abstract	3-002 - Neuroinflammation biomarker in non-fluent/agrammatic variant of primary progressive aphasia and/or apraxia of speech Belen Pascual, PhD
05:30 PM - 06:30 PM PDT	Abstract	3-003 - Active elite rugby participation predicts alterations in right precentral cortical thickness Thomas Parker, PhD, BMBCh, MRCP
05:30 PM - 06:30 PM PDT	Abstract	3-004 - White Matter Hyperintensity on Cholinergic Pathways is Associated with Dementia Severity in e4 Carriers, not in Non-carriers Tracy Ming-Chun Yu, MD
05:30 PM - 06:30 PM PDT	Abstract	3-005 - Neuronal intranuclear inclusion disease (NIID) showing positive results on Pittsburgh Compound-B PET imaging Pu-Tien Chiang, MD
05:30 PM - 06:30 PM PDT	Abstract	12-001 - Neurological Disease Burden in Females with X-linked Adrenoleukodystrophy Natalie Grant
05:30 PM - 06:30 PM PDT	Abstract	12-002 - Imaging Features of Adult-Onset Genetic Leukodystrophies Misdiagnosed as Multiple Sclerosis in Clinical Practice Alise K. Carlson, MD
05:30 PM - 06:30 PM PDT	Abstract	12-003 - Real-world Comparative Effectiveness and Persistence of Cladribine Tablets and Other Oral Disease-Modifying Treatments for Multiple Sclerosis from GLIMPSE: Results from the MSBase Registry Elisabetta Verdun Di Cantogno, MD
05:30 PM - 06:30 PM PDT	Abstract	12-004 - A retrospective evaluation of people with Multiple Sclerosis, to determine factors predicting who declines Disease Modifying Therapies Thomas Jackson
05:30 PM - 06:30 PM PDT	Abstract	12-005 - Outcomes and prognostic factors in myelopathies Maria A. Garcia-Dominguez, MD
05:30 PM - 06:30 PM PDT	Abstract	12-006 - Knowledge, skills, and confidence of healthcare professionals participating in the ECHO MS program
05:30 PM - 06:30 PM PDT	Abstract	12-007 - Regional Atrophy of the Thalamus as a Biomarker for Progressive Multiple Sclerosis Showly Nicholson
05:30 PM - 06:30 PM PDT	Abstract	12-008 - Choroid plexus enlargement in multiple sclerosis is associated with decreased brain volume Niels Bergsland
05:30 PM - 06:30 PM PDT	Abstract	12-009 - DeepGRAI (Deep Gray Rating via Artificial Intelligence) Provides Feasible and Clinically Meaningful Thalamic Volume Measurement on Multi-Center Clinical-Quality T2-FLAIR Images Robert Zivadinov, MD, PhD, FAAN
05:30 PM - 06:30 PM PDT	Abstract	12-010 - White Matter Binding in PET: Pittsburgh Compound-B and Flutemetamol Burcu Zeydan, MD
05:30 PM - 06:30 PM PDT	Abstract	12-011 - Brain Network Centrality Abnormalities Underpin Multiple Sclerosis Disease Course Antonio Carotenuto
05:30 PM - 06:30 PM PDT	Abstract	6-001 - Intractable Epilepsy and Ischemic Strokes in Two Children, both with CACNA1A Gene Mutations Kristen Bolte
05:30 PM - 06:30 PM PDT	Abstract	6-002 - Hemiconvulsion-Hemiplegia-Epilepsy Syndrome in the Setting of COVID-19 Infection and Multisystem Inflammatory Syndrome in Children Paul Gong, MD
05:30 PM - 06:30 PM PDT	Abstract	6-003 - Successful remission with ACTH after early therapeutic pyridoxine fails to prevent the development of infantile spasms in ALDH7A-1-related epilepsy Darrah Haffner, MD
05:30 PM - 06:30 PM PDT	Abstract	6-004 - Diurnal Periodicity in Spontaneously Occurring High-Frequency Oscillations in Intracranial EEG Gabrielle T. Petito, MD
05:30 PM - 06:30 PM PDT	Abstract	6-005 - Epilepsy Characteristics in Children With Neurofibromatosis type 1, What We Have Learnt From a Tertiary Center Five Years’ Experience Abdulhafeez Khair, MD
05:30 PM - 06:30 PM PDT	Abstract	7-001 - Online CME-Certified Expert Panel Discussion Improved Knowledge of Clinically-Relevant Information Regarding Cannabinoids Among Neurologists Thomas Finnegan, Jr., PhD
05:30 PM - 06:30 PM PDT	Abstract	7-002 - A SIGN Group’s Diverse Virtual Neurology Education Programs: Successes, Barriers, and Future Directions Sophia G. Musacchio
05:30 PM - 06:30 PM PDT	Abstract	7-003 - A Simulated Hospital in a COVID-19 Pandemic Environment for Undergraduate Neurology Students. Jaime Toro, MD, FAAN
05:30 PM - 06:30 PM PDT	Abstract	7-004 - Online CME-certified Case Challenges in Migraine Increase Knowledge and Competence Among Neurologists and PCPs Thomas Finnegan, Jr., PhD
05:30 PM - 06:30 PM PDT	Abstract	1-001 - Advanced Practice Providers in Neurocritical Care: Model for Orientation and Onboarding to Ensure Quality of Patient Care, APP Autonomy, Retention and Job Satisfaction Tyler J. Schaefer, PA
05:30 PM - 06:30 PM PDT	Abstract	1-002 - RLS-0071-101 a study in healthy human volunteers demonstrates safety, complement and inflammatory effector target engagement activity of this novel peptide Neel Krishna, PhD
05:30 PM - 06:30 PM PDT	Abstract	1-003 - Diabetic Striatopathy, a rare complication of uncontrolled diabetes: A review of distinct clinical presentations of three different cases Navreet Kaur, MBBS
05:30 PM - 06:30 PM PDT	Abstract	1-004 - Feasibility and safety of the Metaneb® System in neurocritical care patients Evien Albazi
05:30 PM - 06:30 PM PDT	Abstract	1-005 - A Rare Case of Acute Toxic Leukoencephalopathy: Is Sevoflurane the Culprit? Saleem M. Al Mawed, MD
05:30 PM - 06:30 PM PDT	Abstract	1-006 - Guillain-Barre Syndrome after Influenza Vaccination in Adults
05:30 PM - 06:30 PM PDT	Abstract	10-001 - Sustainability of Seizure Control With Adjunctive Cenobamate in the Phase 3 C021 Study David G. Vossler, MD, FAAN
05:30 PM - 06:30 PM PDT	Abstract	10-002 - Phase 2 Open-label Clinical Study Evaluating Oral Ganaxolone for the Treatment of Seizures Associated with Tuberous Sclerosis Complex Mary Kay Koenig, MD
05:30 PM - 06:30 PM PDT	Abstract	10-003 - An Open-Label Pilot Trial Assessing the Safety and Efficacy of SPN-817 (Huperzine A Extended-Release) in Adults with Treatment-Resistant Focal Impaired Awareness Seizures Jeanelle Portelli, PhD
05:30 PM - 06:30 PM PDT	Abstract	10-004 - Fenfluramine Improves Everyday Executive Functioning in Patients With Lennox-Gastaut Syndrome: Analysis of Phase 3 Data Kim I. Bishop, PhD
05:30 PM - 06:30 PM PDT	Abstract	10-005 - Effect of Add-on Cannabidiol (CBD) on Seizure Frequency and Seizure-Free Intervals in Patients With Seizures Associated With Tuberous Sclerosis Complex (TSC): Phase 3 Trial GWPCARE6 Post Hoc Analysis Steven P. Sparagana, MD, FAAN
05:30 PM - 06:30 PM PDT	Abstract	10-006 - Phase 2b Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults with Focal Epilepsy (X-TOLE) Jacqueline French, MD, FAAN
05:30 PM - 06:30 PM PDT	Abstract	10-007 - Efficacy and Safety of Cannabidiol (CBD) Dose Adjustment in Patients With Lennox-Gastaut Syndrome (LGS): Post Hoc Analysis of Phase 3 Randomized Controlled Trial (RCT) GWPCARE3 and Open-Label Extension (OLE) Trial GWPCARE5 Timothy B. Saurer, PhD
05:30 PM - 06:30 PM PDT	Abstract	4-001 - Modified Frailty Index (mFI) in Elderly Patients with Glioblastoma Correlates with Survival Amy K. Chang
05:30 PM - 06:30 PM PDT	Abstract	4-002 - Feasibility of an Electronic Patient Reported Steroid Toxicity Monitoring Program in Patients with Malignant Gliomas Andrea C. Wasilewski, MD
05:30 PM - 06:30 PM PDT	Abstract	4-003 - Disparities in Pediatric Medulloblastoma: A Large Center’s Outcomes and Review of the Literature Karthik Jagannath, MD
05:30 PM - 06:30 PM PDT	Abstract	4-004 - Summary of virtual tumor board platforms and implementation in Neuro-Oncology Chukwuyem Ekhator
05:30 PM - 06:30 PM PDT	Abstract	4-005 - Disparities in Enrollment of Primary CNS Lymphoma Trials in the US Camille Stevenson
05:30 PM - 06:30 PM PDT	Abstract	4-006 - Validation of the Chimeric Antigen Receptor (CAR) T-cell Therapy Neurotoxicity: A Single Center Study Carlen A. Yuen, MD
05:30 PM - 06:30 PM PDT	Abstract	4-007 - The Impact of COVID-19 on Neuro-Oncology Clinical Trials During Wave 1 and Wave 2 at a Frontline Detroit Healthcare System
05:30 PM - 06:30 PM PDT	Abstract	13-001 - Acute Ischemic Stroke Patients Receiving Reperfusion Therapy Do Not Have Worse 90-day Outcomes After Delirium Mohammad Jamil Ahmad, MD
05:30 PM - 06:30 PM PDT	Abstract	13-002 - Predicting Aneurysmal Etiology Using Admission Head CT in Patients with Aneurysmal Pattern Subarachnoid Hemorrhage Karl V. Baumgartner
05:30 PM - 06:30 PM PDT	Abstract	13-003 - Association of External Ventricular Drain Duration and Outcomes in Aneurysmal Subarachnoid Hemorrhage: a Single Center Study
05:30 PM - 06:30 PM PDT	Abstract	13-004 - Association Between Asymptomatic Cerebral Vasospasm and Outcomes in Aneurysmal Subarachnoid Hemorrhage Alizeh Shamshad
05:30 PM - 06:30 PM PDT	Abstract	13-005 - Assessing Thrombectomy Capacity and Characteristics of Thrombectomy Capable Centers World-wide Using the MT2020+ Global Thrombectomy Tracking Smartphone App ? Syed F. Zaidi, MD
05:30 PM - 06:30 PM PDT	Abstract	13-006 - Induction of Vasodilation to Prevent Ophthalmic Complications Before Middle Meningeal Artery Embolization Kiana Moussavi, MD
05:30 PM - 06:30 PM PDT	Abstract	13-007 - Identification of large vessel occlusion on CTA head using artificial intelligence James M. Hillis, MD
05:30 PM - 06:30 PM PDT	Abstract	13-008 - Early Neurological Improvement Can Reduce Intensive Care Unit Length of Stay in Aneurysmal Subarachnoid Hemorrhage Ryan Snow
05:30 PM - 06:30 PM PDT	Abstract	13-009 - Post-Thrombectomy Outcome is Not Associated with Administration of Intravenous Thrombolysis Amanda Zhao, MD
05:30 PM - 06:30 PM PDT	Abstract	13-010 - Blood Pressure Changes Impact Corticospinal Connectivity and Downstream Gait and Balance Control Elizabeth A. Coon, MD, FAAN
05:30 PM - 06:30 PM PDT	Abstract	5-001 - Treatment of Camptocormia in Parkinsonism: A Comparison of Different Interventions in a Single Center Carly J. Olszewski
05:30 PM - 06:30 PM PDT	Abstract	5-002 - A Phase 3, Open-Label, Multi-Center Trial to Evaluate the Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults with Isolated Cervical Dystonia Peter J. McAllister, MD, FAAN
05:30 PM - 06:30 PM PDT	Abstract	5-003 - Rare Variants In ARSA Are Associated With Parkinson's Disease Konstantin Senkevich, MD
05:30 PM - 06:30 PM PDT	Abstract	5-004 - VCP Mutations and Parkinsonism: An Emerging Link Ashley M. Paul, MD
05:30 PM - 06:30 PM PDT	Abstract	5-005 - DNA Methylation-based Surrogates of Plasma Proteins are associated with Parkinson's Disease Risk Katherine Fu, MD
05:30 PM - 06:30 PM PDT	Abstract	5-006 - Transcriptome patterns and their regulation by alternative splicing in Parkinson’s disease. Krithi Irmady, MD, MBBS
05:30 PM - 06:30 PM PDT	Abstract	5-007 - Remote follow up of prodromal Parkinson's disease in a LRRK2 G2019S cohort Ruth Schneider, MD, FAAN
05:30 PM - 06:30 PM PDT	Abstract	2-001 - Neurological Outcomes of Organ Transplantation: A Systematic Review Jenny P. Garzon, MD
05:30 PM - 06:30 PM PDT	Abstract	2-002 - Progressive Multifocal Leukoencephalopathy in immunocompetent a case report and review of literature Syed Hassan Khalid, MD, MBBS
05:30 PM - 06:30 PM PDT	Abstract	2-003 - Treatment Challenges of Active Multiple Sclerosis in the Setting of Cryptococcal Meningitis: A Case Report and Review of the Literature Crystal A. Honold, APN, CNS
05:30 PM - 06:30 PM PDT	Abstract	2-004 - Bannwarth Syndrome Mimicking Neurolymphomatosis Sanem P. Uysal, MD
05:30 PM - 06:30 PM PDT	Abstract	2-005 - Brainstem Gliomatosis Cerebri Presenting as a Cerebellopontine Angle Tumor Kayla Schusterman
05:30 PM - 06:30 PM PDT	Abstract	11-001 - Quantitative muscle analysis in FSHD using Whole-Body MRI: Composite Muscle Measurements for Cross-Sectional Analysis
05:30 PM - 06:30 PM PDT	Abstract	11-002 - Regional Body Composition in Myotonic Dystrophy Type 2: Associations of Lower Extremity Lean Mass Index and Clinical Endpoints Carolyn Foster Aldendail, MD
05:30 PM - 06:30 PM PDT	Abstract	11-003 - ADSSL1 Myopathy: A Case Report David Atherton, MD
05:30 PM - 06:30 PM PDT	Abstract	11-004 - Pharmacokinetics, Biodistribution, and Exploration of the Mechanism of Central Nervous System Penetration of a PATrOL™-Enabled Investigational Genetic Therapy for Myotonic Dystrophy, Type 1 after a Single Subcutaneous or Intravenous Administration in the BALB/c Murine Model Barry A. Badeau, PhD
05:30 PM - 06:30 PM PDT	Abstract	11-005 - Creatine kinase A Novel Prognostic Marker in GBS Kaushik S, Jr., MD
05:30 PM - 06:30 PM PDT	Abstract	11-006 - Sciatic Nerve Mononeuropathy After An Uncomplicated Vaginal Delivery Nader G. Boutros, MD
05:30 PM - 06:30 PM PDT	Abstract	11-007 - Super Slow Conduction Velocities in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Jeremy Zung, MD
05:30 PM - 06:30 PM PDT	Abstract	11-008 - Optimization of intrathecal delivery of an infused AAV9 vector for delivery of a gene therapy candidate for Adrenomyeloneuropathy (AMN) in Non-Human Primates (NHP) Vidyullatha Vasireddy, PhD
05:30 PM - 06:30 PM PDT	Abstract	11-009 - Understanding the Adrenomyeloneuropathy (AMN) Patient Journey Rohan Gandhi, PhD
05:30 PM - 06:30 PM PDT	Abstract	11-010 - Gender Differences in the Development of Cardiomyopathy in Friedreich's Ataxia Patients: A Retrospective Study. Yoona Lee, MD

Faculty Disclosures
Cheryl H. Waters, MD, FAAN	Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for US world meds. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexza. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acadia. Dr. Waters has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bial. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for US world meds. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal.
Sharp J. David, MBBS, PhD	The institution of Prof. David has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rugby Football Union. Prof. David has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Guarantors of Brain. The institution of Prof. David has received research support from UK Dementia Research Institute. The institution of Prof. David has received research support from ADVANCE Charity. The institution of Prof. David has received research support from Action Medical Research. The institution of Prof. David has received research support from Medical Research Council UK.
Durgesh Chaudhary, MBBS	Dr. Chaudhary has nothing to disclose.
Aiden Meyer	Mr. Meyer has received research support from Brown University - Undergraduate Teaching and Research Award.
Bianca Weinstock-Guttman, MD	Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Ulrich Thienel, MD, PhD	Dr. Thienel has received personal compensation for serving as an employee of ReAlta Life Sciences. Dr. Thienel has received stock or an ownership interest from ReAlta Life Sciences.
Setty Magana, MD, PhD	Dr. Magana has nothing to disclose.
Joyutpal Das, MBBS	Dr. Das has nothing to disclose.
Katherine Fu, MD	Dr. Fu has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology: Neurology Journal .
Kranthi K. Mandava	Mr. Mandava has nothing to disclose.
Mohammad Jamil Ahmad, MD	Dr. Ahmad has nothing to disclose.
Michelle L. Mellion, MD	Dr. Mellion has received personal compensation for serving as an employee of PepGen. Dr. Mellion has stock in PepGen.
Sheena K. Aurora, MD	Dr. Aurora has received personal compensation for serving as an employee of Impel Neuropharma. Dr. Aurora has stock in Impel Neurpharma.
	No disclosure on file
Federica Agosta	Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Dejan Jakimovski, MD, PhD	Dr. Jakimovski has nothing to disclose.
Anna Castillo	No disclosure on file
Justin Abbatemarco, MD	Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Abbatemarco has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics, Inc.. The institution of Dr. Abbatemarco has received research support from Horizon.
Kazim Jaffry	Mr. Jaffry has nothing to disclose.
Robert Vann, PhD	Dr. Vann has received personal compensation for serving as an employee of Impel Neuropharma. Dr. Vann has received personal compensation for serving as an employee of Biogen.
Gioacchino Tedeschi, MD	Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Orhun H. Kantarci, MD	Dr. Kantarci has nothing to disclose.
Darrah Haffner, MD	Dr. Haffner has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Naiser Law Office.
Jesse Menville	Ms. Menville has nothing to disclose.
Paola Caroppo	No disclosure on file
Raed Alroughani, MD, FAAN	Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Bayer, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bayer, Biogen, Novartis, Merck, Roche, Sanofi.
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. Dr. Lipton has stock in Axon. Dr. Lipton has stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Meghan E. Pawlik, MS	Miss Pawlik has nothing to disclose.
Jack Grimshaw	Mr. Grimshaw has nothing to disclose.
Thomas J. Kelly, MD	No disclosure on file
Karl V. Baumgartner	Mr. Baumgartner has nothing to disclose.
Anneke Van Der Walt, MD	Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Van Der Walt has received research support from NHMRC Australia. The institution of Dr. Van Der Walt has received research support from MSRA. The institution of Dr. Van Der Walt has received research support from Roche.
Amanda Zhao, MD	Ms. Zhao has nothing to disclose.
Roger J. Porter, MD, FAAN	Dr. Porter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xenon. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Longboard. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axonis. Dr. Porter has received publishing royalties from a publication relating to health care.
Syed F. Zaidi, MD	Dr. Zaidi has nothing to disclose.
Jonathan Graff-Radford, MD, FAAN	Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics.
Barry A. Badeau, PhD	Dr. Badeau has received personal compensation for serving as an employee of NeuBase Therapeutics.
Samir S. Al-Ghazawi, MD	Dr. Al-Ghazawi has nothing to disclose.
Chukwuyem Ekhator	Mr. Ekhator has nothing to disclose.
Nujud Farag, MD	Dr. Farag has nothing to disclose.
Bradford B. Thompson, MD	Dr. Thompson has nothing to disclose.
Guy Laureys, MD, PhD	The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Michael H. Lev, MD	Michael H. Lev, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda, Roche-Genetech. The institution of Michael H. Lev, MD has received research support from GE. Michael H. Lev, MD has received publishing royalties from a publication relating to health care.
Nader G. Boutros, MD	Dr. Boutros has nothing to disclose.
Niral K. Patel, MD	Dr. Patel has nothing to disclose.
Andrea Loggini, MD, MBA	Dr. Loggini has nothing to disclose.
Carlos A. Pardo-Villamizar, MD	The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Brandi L. Anderson, NP	Mrs. Anderson has nothing to disclose.
Viktor Szeder, MD, PhD	Dr. Szeder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Szeder has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Carroll, Kelly, Trotter, Franzen, McBride & Peabody LLP. Dr. Szeder has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Peabody and Buccini LLP.
Alexander Pantelyat, MD, FAAN	Dr. Pantelyat has received personal compensation for serving as an employee of MedRhythms, Inc.. Dr. Pantelyat has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedRhythms, Inc.. Dr. Pantelyat has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Kelly & Ignoffo Law Group. The institution of Dr. Pantelyat has received research support from NIH/NIA.
Federico Silva	No disclosure on file
Saloni Sharma, MBBS	Dr. Sharma has nothing to disclose.
Kelly G. Knupp, MD	Dr. Knupp has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for zogenix. Dr. Knupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for encoded. Dr. Knupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for stoke. The institution of Dr. Knupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW pharmaceuticals. Dr. Knupp has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Research.
Roy Alcalay, MD	Dr. Alcalay has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme/Sanofi. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gain Therapeutics. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vanqua Bio. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Capsida. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. The institution of Dr. Alcalay has received research support from Michael J. Fox Foundation. The institution of Dr. Alcalay has received research support from Parkinson's Foundation. The institution of Dr. Alcalay has received research support from Silverstein Foundation. Dr. Alcalay has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with Parkinson's Foundation.
Burcu Zeydan, MD	The institution of Dr. Zeydan has received research support from National Institutes of Health.
Jessica Tate, MD	The institution of Dr. Tate has received research support from Ipsen. The institution of Dr. Tate has received research support from Boston Scientific. The institution of Dr. Tate has received research support from Revance Therapeutics. The institution of Dr. Tate has received research support from CHDI Foundation. The institution of Dr. Tate has received research support from NINDS. The institution of Dr. Tate has received research support from Michael J. Fox Foundation.
Trisha R. Dickey, MD	Dr. Dickey has nothing to disclose.
Sophia G. Musacchio	Ms. Musacchio has nothing to disclose.
Noah Rosen, MD, FAAN	Dr. Rosen has received personal compensation for serving as an employee of Northwell Health. An immediate family member of Dr. Rosen has received personal compensation for serving as an employee of New York University. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/ Abbvie. Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer . Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/ Abbvie. Dr. Rosen has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Speaker with American Headache Society.
Peggy Auinger	Ms. Auinger has nothing to disclose.
Thomas Jackson	Mr. Jackson has nothing to disclose.
Shubhangi S. Peche, MD	An immediate family member of Dr. Peche has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Silk Road medical .
Leo H. Wang, MD, PhD, FAAN	Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AskBio. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Fulcrum Therapeutics. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Wang has received research support from National Institute of Health. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with US Government.
Oury Monchi, PhD	The institution of Dr. Monchi has received research support from Canadian Health Research Institutes. The institution of Dr. Monchi has received research support from National Science and Engineering and Research Council of Canada. The institution of Dr. Monchi has received research support from Brain Canada Parkinson Canada.
Penina Krieger, MD	Ms. Krieger has nothing to disclose.
Carolyn Foster Aldendail, MD	Dr. Foster Aldendail has nothing to disclose.
Murat Terzi, PhD	Dr. Terzi has nothing to disclose.
Tracy Ming-Chun Yu, MD	Dr. Yu has nothing to disclose.
Sonja W. Scholz, MD, FAAN	Dr. Scholz has received personal compensation for serving as an employee of National Institutes of Health. An immediate family member of Dr. Scholz has received personal compensation for serving as an employee of National Institutes of Health. The institution of Dr. Scholz has received research support from National Institutes of Health. The institution of an immediate family member of Dr. Scholz has received research support from National Institutes of Health. An immediate family member of Dr. Scholz has received intellectual property interests from a discovery or technology relating to health care. Dr. Scholz has a non-compensated relationship as a Scientific Advisory Council Member with Lewy Body Dementia Association that is relevant to AAN interests or activities. Dr. Scholz has a non-compensated relationship as a Editorial Board Member with JAMA Neurology that is relevant to AAN interests or activities. Dr. Scholz has a non-compensated relationship as a Editorial Board Member with Journal of Parkinson's Disease that is relevant to AAN interests or activities. Dr. Scholz has a non-compensated relationship as a Scientific Advisory Board Member with Mission MSA that is relevant to AAN interests or activities. Dr. Scholz has a non-compensated relationship as a Scientific Advisory Board Member with The GBA1 Canada Initiative (G-Can) that is relevant to AAN interests or activities.
Maria A. Rocca	Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Scott Moody	No disclosure on file
Kunal V. Desai, MD	Dr. Desai has nothing to disclose.
Yoona Lee, MD	Ms. Lee has nothing to disclose.
Schiffon Wong	Schiffon Wong has received personal compensation for serving as an employee of EMD Serono.
Matthew Senjem	Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic.
Jai Grewal, MD	The institution of Dr. Grewal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivacitas Oncology. The institution of Dr. Grewal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZeneca. The institution of Dr. Grewal has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BRANY IRB. Dr. Grewal has received stock or an ownership interest from Genomet, Inc. The institution of Dr. Grewal has received research support from Oncoceutics Pharmaceuticals.
Yedda Li, MD, PhD	No disclosure on file
Paula R. Clemens, MD	The institution of Dr. Clemens has received research support from NS Pharma. The institution of Dr. Clemens has received research support from ReveraGen. The institution of Dr. Clemens has received research support from Amicus. The institution of Dr. Clemens has received research support from Sanofi. The institution of Dr. Clemens has received research support from Spark. The institution of Dr. Clemens has received research support from NIH. The institution of Dr. Clemens has received research support from MDA. The institution of Dr. Clemens has received research support from FDA.
Jurriaan Peters, MD	Dr. Peters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Peters has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis.
Kejal Kantarci, MD	The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF.
Alexandra Sankovic, MD	Dr. Sankovic has nothing to disclose.
Ruth Schneider, MD, FAAN	Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Escape Bio. The institution of Dr. Schneider has received research support from The Michael J. Fox Foundation. The institution of Dr. Schneider has received research support from NIH. The institution of Dr. Schneider has received research support from Acadia Pharmaceuticals. The institution of Dr. Schneider has received research support from CHDI. The institution of Dr. Schneider has received research support from Biohaven Pharmaceuticals. The institution of Dr. Schneider has received research support from Parkinson Study Group. The institution of Dr. Schneider has received research support from The Michael J. Fox Foundation. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Telemedicine Evaluator with Parkinson's Foundation.
Alrabi Tawil, MD, FAAN	Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DYNE Therapeutics. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead Pharma. Dr. Tawil has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acceleron Pharma. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT Pharma. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharma. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for miRecule. The institution of Dr. Tawil has received research support from Friends of FSH Research. The institution of Dr. Tawil has received research support from FSH Society. The institution of Dr. Tawil has received research support from NIH. The institution of Dr. Tawil has received research support from Fulcrum. Dr. Tawil has received intellectual property interests from a discovery or technology relating to health care. Dr. Tawil has received publishing royalties from a publication relating to health care.
Abdullah Al-Asmi, MD	No disclosure on file
William E. Rosenfeld, MD, FAAN	The institution of Dr. Rosenfeld has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for SK Life Science. Dr. Rosenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for SK Life Science.
Peter J. McAllister, MD, FAAN	Dr. McAllister has received personal compensation for serving as an employee of Revance. Dr. McAllister has received personal compensation for serving as an employee of AbbVie. Dr. McAllister has received personal compensation for serving as an employee of Merz. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for lilly. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for teva. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for abbvie. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for biohaven. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for lundbeck.
Mustafa S. Siddiqui, MD, FAAN	Dr. Siddiqui has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific Neuromodulation. Dr. Siddiqui has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Siddiqui has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for United States Department of Justice. The institution of Dr. Siddiqui has received research support from Boston Scientific Neuromodulation. The institution of Dr. Siddiqui has received research support from Abbvie. Dr. Siddiqui has received research support from Michael J. Fox Foundation. The institution of Dr. Siddiqui has received research support from National Institute of Health .
Daniele Litterio A. Spitaleri	Daniele Litterio A. Spitaleri has received research support from Novartis.
Natalie Grant	Natalie Grant has nothing to disclose.
Neel Krishna, PhD	Dr. Krishna has received personal compensation for serving as an employee of ReAlta Life Sciences. Dr. Krishna has received intellectual property interests from a discovery or technology relating to health care.
Mohammad Moussavi, MD	Dr. Moussavi has nothing to disclose.
Edoardo G. Spinelli, MD	Dr. Spinelli has nothing to disclose.
Tia Chakraborty, MD	Dr. Chakraborty has nothing to disclose.
Huw R. Morris, MD, PhD	Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Morris has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Personal injury / Negligence cases. The institution of Dr. Morris has received research support from Parkinson's UK. The institution of Dr. Morris has received research support from Michael J Fox Foundartion. The institution of Dr. Morris has received research support from Cure Parkinson's Trust. The institution of Dr. Morris has received research support from PSP Association. The institution of Dr. Morris has received research support from CBD Solutions. The institution of Dr. Morris has received research support from Drake Foundation. The institution of Dr. Morris has received research support from Medical Research Council. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has a non-compensated relationship as a Scientific Advisory Board with Cure PSP that is relevant to AAN interests or activities. Dr. Morris has a non-compensated relationship as a Scientific Advisory Board with Parkinson's UK that is relevant to AAN interests or activities.
Ziv Gan-Or, MD, PhD	Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuron23. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Gan-Or has received personal compensation in the range of $0-$499 for serving as a Consultant for Lighthouse. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Handl Therapeutics. Dr. Gan-Or has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial Biotech.
Shitiz K. Sriwastava, MBBS	Dr. Sriwastava has nothing to disclose.
Michael A. Rogawski, MD, PhD	Dr. Rogawski has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Xenon Pharmaceuticals.
Jonathan Rubin, MD	Dr. Rubin has received personal compensation for serving as an employee of Supernus Pharmaceuticals. Dr. Rubin has received stock or an ownership interest from Supernus Pharmaceuticals. Dr. Rubin has received stock or an ownership interest from Atentiv.
Ashley M. Paul, MD	Dr. Paul has nothing to disclose.
Farhad Sahebkar-Moghaddam, MD	Dr. Sahebkar-Moghaddam has received personal compensation for serving as an employee of Jazz pharmaceuticals. Dr. Sahebkar-Moghaddam has stock in Jazz pharmaceuticals.
Showly Nicholson	Mr. Nicholson has nothing to disclose.
Mark Girgis, DO	Dr. Girgis has nothing to disclose.
Florian Eichler, MD	An immediate family member of Dr. Eichler has received personal compensation for serving as an employee of UpToDate. Dr. Eichler has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for SwanBio Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Eichler has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Origin Biosciences. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orchard Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Autobahn Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bluebird Bio. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. Dr. Eichler has received stock or an ownership interest from SwanBio Therapeutics. The institution of Dr. Eichler has received research support from Bluebird Bio. The institution of Dr. Eichler has received research support from Minoryx Therpeutics. The institution of Dr. Eichler has received research support from Sio Therapeutics. Dr. Eichler has received intellectual property interests from a discovery or technology relating to health care.
Darren Ball	Mr. Ball has nothing to disclose.
Ernesto Aycardi, MD	Dr. Aycardi has received personal compensation for serving as an employee of XENON. Dr. Aycardi has received stock or an ownership interest from XENON.
Linda C. Wendell, MD, FAAN	Dr. Wendell has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. An immediate family member of Dr. Wendell has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Wendell has stock in Apple. An immediate family member of Dr. Wendell has stock in Apple.
Jonatan Hornik, MD	Dr. Hornik has nothing to disclose.
Scott Przybelski	No disclosure on file
Silvia Basaia	Silvia Basaia has nothing to disclose.
Francesca Caso, MD	Dr. Caso has nothing to disclose.
Nicholas S. Potter, MD, PhD	Dr. Potter has nothing to disclose.
Julius Latorre, MD, FAAN	Dr. Latorre has nothing to disclose.
James M. Hillis, MD	Dr. Hillis has stock in Elly Health. The institution of Dr. Hillis has received research support from GE Healthcare. The institution of Dr. Hillis has received research support from Annalise.ai. The institution of Dr. Hillis has received research support from Viz.ai. Dr. Hillis has received intellectual property interests from a discovery or technology relating to health care.
Alicia Zha, MD	Dr. Zha has nothing to disclose.
Kourosh Rezania, MD, FAAN	Dr. Rezania has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Akcea. Dr. Rezania has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam.
Kara R. Melmed, MD	Dr. Melmed has nothing to disclose.
Serge Przedborski, MD, PhD	Dr. Przedborski has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for eLife. The institution of Dr. Przedborski has received research support from NIH. The institution of Dr. Przedborski has received research support from DoD. The institution of Dr. Przedborski has received research support from Ludwig Foudantion. The institution of Dr. Przedborski has received research support from CZI.
Stanley Fahn, MD, FAAN	Dr. Fahn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Stoparkinson Healthcare Systems, LLC; . Dr. Fahn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin Inc . Dr. Fahn has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Publishers . Dr. Fahn has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Kirkland & Ellis. Dr. Fahn has received publishing royalties from a publication relating to health care.
Salim Chahin, MD	Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen. The institution of Dr. Chahin has received research support from National MS Society. The institution of Dr. Chahin has received research support from BMS.
Tracy J. Koehler	Tracy J. Koehler has nothing to disclose.
Hsin-Hsi Tsai, MD	Dr. Tsai has nothing to disclose.
Stephen Falchek, MD	Dr. Falchek has nothing to disclose.
Jeanelle Portelli, PhD	Dr. Portelli has received personal compensation for serving as an employee of Supernus Pharmaceuticals, Inc..
Praveen Ramani, MBBS	Dr. Ramani has nothing to disclose.
Lynda Krasenbaum	Lynda Krasenbaum has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Mohammad O. Nakawah, MD, FAAN	Dr. Nakawah has nothing to disclose.
Jeremy Zung, MD	Dr. Zung has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Internal Medicine Review.
Santosh Kesari, MD, PhD, FAAN	Dr. Kesari has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for xcures. Dr. Kesari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Duke.
Kristen Bolte	Miss Bolte has nothing to disclose.
Ahmed Z. Obeidat, MD, PhD	Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genentech. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon pharmaceuticals . Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sandoz. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for EMD Serono. Dr. Obeidat has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner life sciences . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Expert opinion and key opinion leader with MJH life sciences . Dr. Obeidat has a non-compensated relationship as a Board member with CMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Editorial Board Member with IJMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Reviewer Editor with Frontiers Neurology that is relevant to AAN interests or activities.
Rajeshwari Mahalingam, MD	Dr. Mahalingam has nothing to disclose.
Araya Puwanant, MD	The institution of Dr. Puwanant has received research support from Muscular Dystrophy Association. The institution of Dr. Puwanant has received research support from NIH/NINDS. The institution of Dr. Puwanant has received research support from NIH/NINDS.
Katy Eichinger, PhD, PT, DPT, NCS	Dr. Eichinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Fulcrum. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avidity. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DyneTherapeutic. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Eichinger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for FSHD Society. The institution of Dr. Eichinger has received research support from Charcot Marie Tooth Association.
Robert Zivadinov, MD, PhD, FAAN	The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Filterlex. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for 3D Communications. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Live. The institution of Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Bethanie N. Morgan, MD	Dr. Morgan has nothing to disclose.
Jorge A. Vidaurre, MD	Dr. Vidaurre has nothing to disclose.
Elaine C. Wirrell, MD, FAAN	Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Wirrell has received publishing royalties from a publication relating to health care.
Crystal A. Honold, APN, CNS	Mrs. Honold has nothing to disclose.
Rohan Gandhi, PhD	Dr. Gandhi has received personal compensation for serving as an employee of Autobahn Therapeutics. Dr. Gandhi has stock in Autobahn Therapeutics.
Paolo Zanotti Fregonara	Paolo Zanotti Fregonara has nothing to disclose.
Violiza A. Inoa, MD	No disclosure on file
Amy K. Chang	Miss Chang has nothing to disclose.
Jiwon Oh, MD, FAAN	Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Oh has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen-Idec. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Oh has received research support from Biogen-Idec. The institution of Dr. Oh has received research support from Roche.
Sanem P. Uysal, MD	Dr. Uysal has nothing to disclose.
Nabeel Herial, MD, MPH, FAAN	Dr. Herial has nothing to disclose.
Robert G. Holloway, MD, MPH, FAAN	Dr. Holloway has nothing to disclose.
Brenda E. Porter, MD, PhD	An immediate family member of Dr. Porter has received personal compensation for serving as an employee of Sangamo. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taysha. An immediate family member of Dr. Porter has received stock or an ownership interest from Johnson and Johnson.
Linda Harris, MPH	Ms. Harris has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Ms. Harris has received stock or an ownership interest from Biohaven Pharmaceuticals.
Jeffrey A. Cohen, MD	Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FiND. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for INMune. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage.
Camille Stevenson	Miss Stevenson has nothing to disclose.
Ryan Snow	Mr. Snow has nothing to disclose.
Chan Beals	Chan Beals has received personal compensation for serving as an employee of Autobahn Therapeutics.
Lauren Hurst	Ms. Hurst has nothing to disclose.
Kaitlin Schoder, NP	Ms. Schoder has nothing to disclose.
Konstantin Senkevich, MD	The institution of Dr. Senkevich has received research support from MJFF. Dr. Senkevich has received research support from HBHL. Dr. Senkevich has received research support from FRQS.
Andrew Russo	Andrew Russo has nothing to disclose.
Giuseppe Magnani	Giuseppe Magnani has nothing to disclose.
Bassem I. Yamout, MD, FAAN	Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Adrienne M. Keener, MD	Dr. Keener has nothing to disclose.
Elijah M. Persad-Paisley	Mr. Persad-Paisley has nothing to disclose.
Patrizia Pantano	Patrizia Pantano has nothing to disclose.
Sara E. Sacco, MD	The institution of Dr. Sacco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie/Allergan. The institution of Dr. Sacco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. The institution of Dr. Sacco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Sacco has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Impel Neuropharma. The institution of Dr. Sacco has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TEVA. The institution of Dr. Sacco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI (Now Collegium). The institution of Dr. Sacco has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/Abbvie. The institution of Dr. Sacco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Sacco has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. The institution of Dr. Sacco has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. Sacco has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel NeuroPharma. Dr. Sacco has received personal compensation in the range of $10,000-$49,999 for serving as a Key Opinion Leader with Teva.
Elizabeth Michel, PA	Mrs. Michel has nothing to disclose.
Emile S. Moukheiber, MD	Dr. Moukheiber has nothing to disclose.
Mohamed Fahmy Doheim	Mr. Doheim has nothing to disclose.
Nkechi Obianozie, MBBS	Dr. Obianozie has nothing to disclose.
Syed Hassan Khalid, MD, MBBS	Dr. Khalid has nothing to disclose.
Kehan Zhao, MD	Dr. Zhao has nothing to disclose.
Santiago Ortega Gutierrez, MD	Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for stryker. Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Ortega Gutierrez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for microvention. Dr. Ortega Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Dr. Ortega Gutierrez has received research support from stryker. The institution of Dr. Ortega Gutierrez has received research support from Medtronic. The institution of Dr. Ortega Gutierrez has received research support from Methinks. The institution of Dr. Ortega Gutierrez has received research support from NIH.
Tamara Zach, MD, FAAN	Dr. Zach has nothing to disclose.
Robert I. Reid	No disclosure on file
Jennifer A. Frontera, MD	Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FirstKindMedical. Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Physician Education Resource. The institution of Dr. Frontera has received research support from NIH. The institution of Dr. Frontera has received research support from Alexion. Dr. Frontera has received publishing royalties from a publication relating to health care.
Sisira Yadala, MD, FAAN	Dr. Yadala has nothing to disclose.
Gloria Von Geldern, MD, FAAN	The institution of Dr. Von Geldern has received research support from Novartis. The institution of Dr. Von Geldern has received research support from National MS Society. Dr. Von Geldern has received personal compensation in the range of $0-$499 for serving as a DSMB member with NIH, NINDS. Dr. Von Geldern has a non-compensated relationship as a editorial board member with MS and Related Disorders Journal that is relevant to AAN interests or activities.
Michael L. Reed, PhD	The institution of Dr. Reed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Reed has received research support from Allergan. The institution of Dr. Reed has received research support from Dr Reddy's Labs/Promius. The institution of Dr. Reed has received research support from Allay Lamp. Dr. Reed has a non-compensated relationship as a Research Analyst with National Headache Foundation that is relevant to AAN interests or activities.
Yi-Chien Liu, MD	Dr. Liu has nothing to disclose.
John A. Morren, MD, FAAN	Dr. Morren has received publishing royalties from a publication relating to health care.
Suzanne J. Hodgkinson, MD, MBBS, PhD, FRACP	The institution of Dr. Hodgkinson has received research support from MERCK. The institution of Dr. Hodgkinson has received research support from Atara. The institution of Dr. Hodgkinson has received research support from Biogen . The institution of Dr. Hodgkinson has received research support from Genzyme. The institution of Dr. Hodgkinson has received research support from ROCHE. The institution of Dr. Hodgkinson has received research support from Novartis.
Salman Zahoor, MBBS	Dr. Zahoor has nothing to disclose.
Gilbert J. L'Italien	Gilbert J. L'Italien has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gilbert J. L'Italien has stock in biohaven pharmaceuticals.
Vladimir Coric	Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
Ayse Altintas, MD	Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Deva. The institution of Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Hira Zafar, MBBS	Dr. Zafar has nothing to disclose.
Emmanuel Obusez	No disclosure on file
Jared Macher	Mr. Macher has nothing to disclose.
Gagana K. Mallawaarachchi	Mr. Mallawaarachchi has nothing to disclose.
Yvette Bordelon, MD, FAAN	Dr. Bordelon has nothing to disclose.
Ian Miller, MD	Dr. Miller has received personal compensation for serving as an employee of Marinus Pharmaceuticals. Dr. Miller has stock in Marinus Pharmaceuticals.
Pu-Tien Chiang, MD	Dr. Chiang has nothing to disclose.
Laura A. Serna	Miss Serna has nothing to disclose.
Charles Maitland	No disclosure on file
Harini Pavuluri	Harini Pavuluri has nothing to disclose.
Ahmad A. Ballout, MD	Dr. Ballout has nothing to disclose.
Jairo A. Gaitan Alfonso, MD	Dr. Gaitan Alfonso has nothing to disclose.
Michael Seminerio	Michael Seminerio has received personal compensation for serving as an employee of AbbVie.
Jorge L. Rodriguez Lee, MD	Dr. Rodriguez Lee has nothing to disclose.
Anand R. Shewale	Anand R. Shewale has received personal compensation for serving as an employee of AbbVie. Anand R. Shewale has stock in AbbVie.
Veronica Castelnovo, MSc	Dr. Castelnovo has nothing to disclose.
Sandra Rojas-Caro, MD	Dr. Rojas-Caro has received personal compensation for serving as an employee of Gemini Therapeutics. Dr. Rojas-Caro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for HemoShear Therapeutics. Dr. Rojas-Caro has stock in Neubase Therapeutics.
Jumana T. Alshaikh, MD	Dr. Alshaikh has nothing to disclose.
Michael D. Kolesnik, DO	Dr. Kolesnik has nothing to disclose.
Aysun Soysal, MD	Dr. Soysal has nothing to disclose.
Domenico Vitarella	No disclosure on file
Muhib Khan, MD, FAAN	The institution of Dr. Khan has received research support from NINDS. The institution of Dr. Khan has received research support from Genentech. The institution of Dr. Khan has received research support from Spectrum Health-MSU alliance. Dr. Khan has received research support from NIH.
Katherine D. Amodeo, MD	The institution of Dr. Amodeo has received research support from Roche. The institution of Dr. Amodeo has received research support from EIP Pharma. The institution of Dr. Amodeo has received research support from Acadia. The institution of Dr. Amodeo has received research support from MJFF. The institution of Dr. Amodeo has received research support from NINDS.
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi;. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi- Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Etienne Laverse, MBBS, BSc, MRCP	Dr. Laverse has nothing to disclose.
Yves Dauvilliers, MD, PhD	Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for idorsia. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for JAZZ. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel.
Isabella Canut	Ms. Canut has nothing to disclose.
Ali Mahta, MD	Dr. Mahta has nothing to disclose.
E. Ray Dorsey, MD, MBA	Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BrainNeuroBio. Dr. Dorsey has received personal compensation in the range of $0-$499 for serving as a Consultant for Clintrex. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curasen Therapeutics. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali Therapeutics. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Dorsey has received personal compensation in the range of $0-$499 for serving as a Consultant for Grand Rounds. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medopad. Dr. Dorsey has received personal compensation in the range of $0-$499 for serving as a Consultant for Michael J. Fox Foundation. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Origent Data Sciences, Inc.. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Otsuka. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Spark. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion Pharma. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theravance. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Voyager Therapeutics. Dr. Dorsey has received personal compensation in the range of $0-$499 for serving as a Consultant for Alzheimer's Drug Discovery Foundation. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial-Biotech Investments, Inc.. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BluePrint Orphan, Inc.. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Caraway T. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DeciBio. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mediflix. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NACCME/CONSULTANT 360. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Dorsey has received personal compensation in the range of $0-$499 for serving as a Consultant for Olson Research Group. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pear Therapeutics. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Spark. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Caraway. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Huntington Study Group. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Voyager. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech/Roche. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ANA. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MCM Education. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Physician's Education Resource, LLC. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Texas Neurological Society. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Karger. Dr. Dorsey has stock in Grand Rounds. The institution of Dr. Dorsey has received research support from Biogen - WATCH-PD. The institution of Dr. Dorsey has received research support from NIH - AHPD. Dr. Dorsey has received research support from NIH - Biosensics. The institution of Dr. Dorsey has received research support from Pfizer - SQUAD. The institution of Dr. Dorsey has received research support from Greater Rochester Health Foundation - PDCNY. The institution of Dr. Dorsey has received research support from Safra Foundation - PDCNY. The institution of Dr. Dorsey has received research support from Burroughs Wellcome - Smartphones. The institution of Dr. Dorsey has received research support from NIH - CTSA. The institution of Dr. Dorsey has received research support from Gary & Mary West Foundation - d.health. The institution of Dr. Dorsey has received research support from PCORI -PD Virtual Care. The institution of Dr. Dorsey has received research support from WAVE Life Sciences. The institution of Dr. Dorsey has received research support from Acadia Pharmaceuticals - PDTV. The institution of Dr. Dorsey has received research support from Roche Pharmaceuticals - PDTV. The institution of Dr. Dorsey has received research support from Michael J. Fox Foundation - Fox Insight. The institution of Dr. Dorsey has received research support from Michael J. Fox Foundation - Emerald. The institution of Dr. Dorsey has received research support from PCORI. The institution of Dr. Dorsey has received research support from Safra Foundation.
Evien Albazi	Mrs. Albazi has nothing to disclose.
Helmut Butzkueven, MD, MBBS	Dr. Butzkueven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oxford Health Policy Forum. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for MSBase . The institution of Dr. Butzkueven has received research support from NHMRC. The institution of Dr. Butzkueven has received research support from Biogen. The institution of Dr. Butzkueven has received research support from Roche. The institution of Dr. Butzkueven has received research support from Novartis.
Cynthia L. Harden, MD	Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
Aaron Lord, MD	Dr. Lord has nothing to disclose.
Azam Tolla, DO	Dr. Tolla has nothing to disclose.
Ravindra Arya	The institution of Ravindra Arya has received research support from National Institutes of Health. The institution of Ravindra Arya has received research support from Cincinnati Children's Research Foundation.
Kayla Schusterman	Ms. Schusterman has nothing to disclose.
Daniela S. Rodriguez	Ms. Rodriguez has nothing to disclose.
Delanie Lynch	Ms. Lynch has nothing to disclose.
GURCHARANJEET KAUR, MBBS	Dr. Kaur has nothing to disclose.
Roman Rubio	Roman Rubio has received personal compensation for serving as an employee of Revance.
Brad Kemp	Brad Kemp has nothing to disclose.
Kaushik S, Jr., MD	Dr. S has nothing to disclose.
Maryam Zulfiqar, MD	Dr. Zulfiqar has nothing to disclose.
Andrea C. Wasilewski, MD	Dr. Wasilewski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure.
Alizeh Shamshad	Ms. Shamshad has nothing to disclose.
Muhammad S. Zafar, MBBS	Dr. Zafar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharmaceuticals. Dr. Zafar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova . The institution of Dr. Zafar has received research support from UCB. The institution of Dr. Zafar has received research support from SK life. The institution of Dr. Zafar has received research support from Marinus. The institution of Dr. Zafar has received research support from LivaNova. The institution of Dr. Zafar has received research support from Biopharma. The institution of Dr. Zafar has received research support from Neurocrine. The institution of Dr. Zafar has received research support from Hartwell Foundation.
Sara Prioni	No disclosure on file
Souhel Najjar, MD	Dr. Najjar has nothing to disclose.
Jeff M. Bronstein, MD, PhD	Dr. Bronstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ultragenyx. The institution of Dr. Bronstein has received research support from NIH. The institution of Dr. Bronstein has received research support from Levine Foundation.
Fatima I. Abdulai, MBBS	Dr. Abdulai has nothing to disclose.
Timothy Spelman	No disclosure on file
Carly J. Olszewski	Ms. Olszewski has nothing to disclose.
Richard A. Macdonell, MD, FAAN	Dr. Macdonell has nothing to disclose.
Nikolaos Petsas	No disclosure on file
Paola Valsasina	No disclosure on file
Gregory Brooks	No disclosure on file
Serkan Ozakbas, MD	Dr. Ozakbas has nothing to disclose.
Val J. Lowe, MD	Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Annette Wundes, MD, FAAN	The institution of Dr. Wundes has received research support from Benaroya Research Institute .
Elena Schmidt, MD	Dr. Schmidt has nothing to disclose.
Frederik Barkhof, MD, PhD	Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
Sean Stern	Mr. Stern has received personal compensation for serving as an employee of SK Life Science.
David G. Vossler, MD, FAAN	Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $0-$499 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Longboard Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. The institution of Dr. Vossler has received research support from SK Life Science. The institution of Dr. Vossler has received research support from Xenon Pharmaceuticals. The institution of Dr. Vossler has received research support from Longboard Pharmaceuticals.
Brandon Francis, MD	Dr. Francis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovian. Dr. Francis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Montgomery and Associates.
Blanca Y. Valdovinos, MD	Dr. Valdovinos has nothing to disclose.
Gail M. Farfel, PhD	Dr. Farfel has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Durect Corp. Dr. Farfel has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Zogenix. Dr. Farfel has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for AvroBio. Dr. Farfel has received intellectual property interests from a discovery or technology relating to health care.
Elizabeth Thiele, MD	Dr. Thiele has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GW Pharma/Jazz. Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for zogenix/UCB. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for nobelpharma. An immediate family member of Dr. Thiele has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Thor labs. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for takeda. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for livanova. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azurity. Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. The institution of Dr. Thiele has received research support from GW Pharma/Jazz. The institution of Dr. Thiele has received research support from Zogenix/UCB. The institution of Dr. Thiele has received research support from Stoke Therapeutics.
Rajsekar R. Rajaraman, MD	Dr. Rajaraman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Marinus Pharmacueticals.
Johanna Appleton	No disclosure on file
Karthik Jagannath, MD	Mr. Jagannath has nothing to disclose.
Joseph Zachariah, DO	Dr. Zachariah has nothing to disclose.
Nimish A. Mohile, MD, FAAN	Dr. Mohile has nothing to disclose.
Antonio Gallo	Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis.
Ralph H. Benedict, PhD	Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Benedict has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Benedict has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Brystal Mier Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Benedict has received research support from Genzyme. The institution of Dr. Benedict has received research support from Biogen. The institution of Dr. Benedict has received research support from Bristol Myer Squib. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Mark B. Skeen, MD, FAAN	Dr. Skeen has received personal compensation for serving as an employee of VeraSci. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD/Serono. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squib. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD/ Serono. The institution of Dr. Skeen has received research support from National MS Society. Dr. Skeen has received personal compensation in the range of $50,000-$99,999 for serving as a Retiree with US Navy.
David R. Beers, PhD	No disclosure on file
Martin Brodie	No disclosure on file
James P. Kesslak, PhD	Dr. Kesslak has received personal compensation for serving as an employee of Alzheon. Dr. Kesslak has stock in Prime First Lending.
Vincenzo Silani, MD, FAAN	Dr. Silani has nothing to disclose.
Rashid A. Ahmed, MD	Dr. Ahmed has nothing to disclose.
Alejandro Hornik, MD	Dr. Hornik has nothing to disclose.
Timothy B. Saurer, PhD	Dr. Saurer has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Saurer has stock in Jazz Pharmaceuticals.
Caroline M. Tanner, MD, PhD, FAAN	Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evidera. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals/Cavion. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial . Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Genentech. The institution of Dr. Tanner has received research support from Gateway LLC. The institution of Dr. Tanner has received research support from Roche\Genentech. The institution of Dr. Tanner has received research support from Michael J Fox Foundation . The institution of Dr. Tanner has received research support from National Institute of Health . The institution of Dr. Tanner has received research support from Department of Defense. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Faculty, CME presentation with Medscape /WebND.
Christopher J. Kenney, MD, FAAN	Dr. Kenney has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Kenney has stock in Xenon Pharmaceuticals.
Dietrich A. Stephan, PhD	Dr. Stephan has received personal compensation for serving as an employee of NeuBase Therapeutics, Inc.. Dr. Stephan has received stock or an ownership interest from Peptilogics, Inc.. Dr. Stephan has received stock or an ownership interest from Sharp Edge Labs, Inc.. Dr. Stephan has received stock or an ownership interest from Pendulum Therapeutics, Inc.. Dr. Stephan has received stock or an ownership interest from FarmaceuticalRx.
Emilio Perucca	No disclosure on file
Jenny P. Garzon, MD	Dr. Garzon has nothing to disclose.
Karen Kozarsky, PhD	Dr. Kozarsky has received personal compensation for serving as an employee of SwanBio Therapeutics. Dr. Kozarsky has received stock or an ownership interest from SwanBio Therapeutics.
Mohamed S. Zaazouee	Mr. Zaazouee has nothing to disclose.
Brenda Shen	Ms. Shen has nothing to disclose.
Thomas Parker, PhD, BMBCh, MRCP	Dr. Parker has nothing to disclose.
Gabrielle T. Petito, MD	Miss Petito has nothing to disclose.
Leah Croll, MD	Dr. Croll has nothing to disclose.
Camilla Cividini, MSc	Ms. Cividini has nothing to disclose.
Erum Khan	Ms. Khan has nothing to disclose.
Maurice Driessen	No disclosure on file
Natasha Hameed, MD	Dr. Hameed has nothing to disclose.
Stanley H. Appel, MD, FAAN	Dr. Appel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Appel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eledon. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Implicit. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Coya Therapeutics. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Muscular Disease Association. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Therapy Development Institute. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Finding a Cure. Dr. Appel has stock in Stock holdings in retirement acct at Fidelity. The institution of Dr. Appel has received research support from Coya Therapeutics.
Diego Silva	Diego Silva has received personal compensation for serving as an employee of BMS. Diego Silva has received stock or an ownership interest from BMS.
John R. Mytinger, MD	Dr. Mytinger has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Walter Kremers	No disclosure on file
Hildalicia Guerra, MD	Dr. Guerra has nothing to disclose.
Francesco Patti, MD	Dr. Patti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Almirall, Bayer, Biogen, Bristol Meyers and Squibb Merck, Roche, Sanofi, TEVA. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for University of Catania and AISM/FISM, Fondazione Italiana Sclerosi Multipla.
Saleem M. Al Mawed, MD	Dr. Al Mawed has nothing to disclose.
Christopher Schwarz	No disclosure on file
Karen L. Furie, MD	The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. Dr. Furie has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS.
Vidyullatha Vasireddy, PhD	Dr. Vasireddy has stock in SwanBio Therapeutics.
Alissa A. Thomas, MD, FAAN	The institution of Dr. Thomas has received research support from Novocure. The institution of Dr. Thomas has received research support from Ono Pharmaceuticals.
Baziel G. van Engelen, MD, PhD, MA	The institution of Dr. van Engelen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Facio. The institution of Dr. van Engelen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum . The institution of Dr. van Engelen has received research support from Stichting Spieren voor Spieren. The institution of Dr. van Engelen has received research support from Prinses Beatrix Fonds. The institution of Dr. van Engelen has received research support from Dutch FSHD society. Dr. van Engelen has received intellectual property interests from a discovery or technology relating to health care.
Perry Shieh, MD, PhD, FAAN	Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Grifols. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Shieh has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst.
Ayatalla Ahmed, MBBS	Dr. Ahmed has nothing to disclose.
Christoph Stretz, MD, FAAN	Dr. Stretz has nothing to disclose.
Timothy Lesnick	No disclosure on file
Tyler J. Schaefer, PA	Mr. Schaefer has nothing to disclose.
Koto Ishida, MD, FAAN	Dr. Ishida has received publishing royalties from a publication relating to health care.
Ildebrando H. Appollonio, MD	Dr. Appollonio has nothing to disclose.
Benjamin C. Grant, PA	Mr. Grant has nothing to disclose.
Clifford R. Jack, Jr., MD	The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Sutapa Ray, PhD	Dr. Ray has received personal compensation for serving as an employee of Impel Pharmaceuticals. Dr. Ray has stock in Impel Pharmaceuticals.
Ariane Lewis, MD, FAAN	Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seminars in Neurology. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
David W. Anderson, PhD	Dr. Anderson has received personal compensation for serving as an employee of SwanBio Therapeutics Inc. Dr. Anderson has received personal compensation for serving as an employee of Spark Therapeutics Inc. An immediate family member of Dr. Anderson has received personal compensation for serving as an employee of GSK. An immediate family member of Dr. Anderson has received personal compensation for serving as an employee of Novartis. Dr. Anderson has stock in SwanBio Therapeutics Inc. An immediate family member of Dr. Anderson has stock in GSK. Dr. Anderson has stock in Roche . An immediate family member of Dr. Anderson has stock in Novartis.
Stella Jensen-Roberts	Ms. Jensen-Roberts has nothing to disclose.
Jacqueline French, MD, FAAN	Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. Dr. French has received personal compensation in the range of $100,000-$499,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Angelini that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Bright minds Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Arvelle that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Beacon biosignals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bloom Science Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with BridgeBio Pharma Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, scientific advisory board with Camp4 Therapeutics Corporation that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Scientific Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Coda Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Genentech Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Eisai, that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Eliem Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Epihunter that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Epiminder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Equilibre BioPharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Greenwich Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with GW Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Janssen Pharmaceutica that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Jazz Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Knopp Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Lipocine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with LivaNova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Longboard Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Lundbeck that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant,SAB with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neuroelectrics USA Corporation that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neuronetics Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Ono Pharmaceutical Co that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Otsuka Pharmaceutical Development that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Ovid Therapeutics Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Paladin Labs Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LTY Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with SK Life Sciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with UCB Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, steering committee with Xenon that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Korro Bio Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory board with Receptor that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory board with Sage Therpeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Third Rock Ventures that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Pfizer that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Agrithera, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting with Autifony therapeutics, Unlimited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Baergic Bio that is relevant to AAN interests or activities.
Barry E. Gidal, PhD	Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai . Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich. Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SK life sciences . Dr. Gidal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK life science .
Jaya R. Trivedi, MD, FAAN	Dr. Trivedi has nothing to disclose.
James Snyder, DO	Dr. Snyder has nothing to disclose.
Todd Gross	Todd Gross has received personal compensation for serving as an employee of Revance Therapeutics Inc. Todd Gross has stock in Revance Therapeutics Inc.
Belen Pascual, PhD	The institution of Prof. Pascual has received research support from NIH. The institution of Prof. Pascual has received research support from NIH.
Bethany Williams, PhD	Dr. Williams has received research support from UTHealth at Houston.
Gerard A. Gioia, MD	Dr. Gioia has received personal compensation in the range of $0-$499 for serving as a Consultant for Global Pharma Consultancy. Dr. Gioia has received publishing royalties from a publication relating to health care.
Gregory Busse	Gregory Busse has received personal compensation for serving as an employee of Supernus Pharmaceuticals.
Danielle Diekevers	Danielle Diekevers has nothing to disclose.
Ronald C. Petersen, MD, PhD, FAAN	Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nestle. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Steven P. Sparagana, MD, FAAN	Dr. Sparagana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Biosciences. Dr. Sparagana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nobelpharma. The institution of Dr. Sparagana has received research support from Greenwich Biosciences. The institution of Dr. Sparagana has received research support from Tuberous Sclerosis Alliance. The institution of Dr. Sparagana has received research support from Novartis. Dr. Sparagana has a non-compensated relationship as a Professional Advisory Board Member, committee member with Tuberous Sclerosis Alliance that is relevant to AAN interests or activities.
Thomas F. Medina Ramirez	Mr. Medina Ramirez has nothing to disclose.
Carlen A. Yuen, MD	Dr. Yuen has nothing to disclose.
Jay Han, MD	No disclosure on file
John Maeglin	Mr. Maeglin has nothing to disclose.
Maria A. Garcia-Dominguez, MD	Dr. Garcia-Dominguez has nothing to disclose.
Michelle M. Mielke, PhD	Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunbird Bio. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk.
Jaime Toro, MD, FAAN	Dr. Toro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Watch Neurology .
David Atherton, MD	Dr. Atherton has nothing to disclose.
Mary Kay Koenig, MD	Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Marinus Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stealth BioTherapeutics. Dr. Koenig has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reneo Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. The institution of Dr. Koenig has received research support from Abliva AB. The institution of Dr. Koenig has received research support from EryDel SPA. The institution of Dr. Koenig has received research support from PTC Therapeutics. The institution of Dr. Koenig has received research support from Noema Pharmaceuticals. The institution of Dr. Koenig has received research support from Marinus Pharmaceuticals. The institution of Dr. Koenig has received research support from Jazz Pharmaceuticals. The institution of Dr. Koenig has received research support from Nflexion Therapeutics. The institution of Dr. Koenig has received research support from Stealth BioTherapeutics. The institution of Dr. Koenig has received research support from Astellas Pharmaceuticals. The institution of Dr. Koenig has received research support from Reneo Pharmaceuticals.
Alexandra Helliwell	Ms. Helliwell has nothing to disclose.
Nayana Prabhu, MD	Dr. Prabhu has nothing to disclose.
Robert T. Wechsler, MD, PhD, FAAN	The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Engage. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eliem. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epalex. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Equilibre. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Raport. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sunovion. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Greenwich. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aquestive. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. Dr. Wechsler has a non-compensated relationship as a Board President with Epilepsy Foundation of Idaho that is relevant to AAN interests or activities.
Sahar S. Anjum, MS	Miss Anjum has nothing to disclose.
Antonio Carotenuto	Mr. Carotenuto has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk, Novartis, Roche and Almirall. The institution of Mr. Carotenuto has received research support from ALMIRALL. The institution of Mr. Carotenuto has received research support from Carotenuto Antonio.
Vincent Van Pesch, MD, PhD	Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Vincent Van Pesch, MD, PhD has received research support from Biogen.
Jeannette Lechner-Scott, MD, PhD, FRACP	The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for elsevier. The institution of Prof. Lechner-Scott has received research support from Merck. The institution of Prof. Lechner-Scott has received research support from Biogen.
Prashanthi Vemuri, PhD	The institution of Dr. Vemuri has received research support from NIH.
Diana A. Madrid, MS	Miss Madrid has received personal compensation in the range of $10,000-$49,999 for serving as a Grantee with Institute of Internation Education. Miss Madrid has received personal compensation in the range of $500-$4,999 for serving as a Early Investigator Travel Award with American Society for Bone and Mineral Research. Miss Madrid has received personal compensation in the range of $0-$499 for serving as a Travel Award with American Neurological Association.
Joseph C. Masdeu, MD, PhD, FAAN	Dr. Masdeu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Moody Foundation. The institution of Dr. Masdeu has received research support from Biogen. The institution of Dr. Masdeu has received research support from Eli Lilly. The institution of Dr. Masdeu has received research support from Eisai. The institution of Dr. Masdeu has received research support from Novartis. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE.
Bhavesh Trikamji, MD	Dr. Trikamji has nothing to disclose.
Darcy Krueger, MD	Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NobelPharma USA. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for RegenxBio. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharmaceuticals. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Greenwich Biosciences. The institution of Dr. Krueger has received research support from Greenwich Bioscience. The institution of Dr. Krueger has received research support from Marinus Pharmaceuticals. The institution of Dr. Krueger has received research support from National Institutes of Health. The institution of Dr. Krueger has received research support from Food and Drug Administration. The institution of Dr. Krueger has received research support from TSC Alliance.
Tobias Walbert, MD, PhD, FAAN	Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AnHeart.
Yolanda Blanco Morgado, MD	Dr. Blanco Morgado has nothing to disclose.
Jose L. Torres, MD	Dr. Torres has nothing to disclose.
Manuel S. Yepes, MD	Dr. Yepes has nothing to disclose.
Paul Gong, MD	Dr. Gong has nothing to disclose.
Ezgi Saylam, MD	Dr. Saylam has nothing to disclose.
Stephen B. Shrewsbury, MD	Dr. Shrewsbury has received personal compensation for serving as an employee of Impel NeuroPharma. Dr. Shrewsbury has received stock or an ownership interest from Impel NeuroPharma.
Diego Cadavid, MD, FAAN	Dr. Cadavid has received personal compensation for serving as an employee of X4 Pharma. Dr. Cadavid has received personal compensation for serving as an employee of Fulcrum Therapeutics. Dr. Cadavid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvinas. Dr. Cadavid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abata Therapeutics. Dr. Cadavid has received stock or an ownership interest from X4 Pharma. Dr. Cadavid has received stock or an ownership interest from Fulcrum Therapeutics.
Elizabeth A. Coon, MD, FAAN	Dr. Coon has nothing to disclose.
Radek Ampapa, MD	Dr. Ampapa has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Ampapa has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Ampapa has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzym.
Brendan Lujan, PhD	Dr. Lujan has received personal compensation for serving as an employee of Supernus Pharmaceuticals, Inc..
Milad Sabouri, DO	Dr. Sabouri has nothing to disclose.
Aditya Kumar, MD	Dr. Kumar has nothing to disclose.
Julia M. Soto, MPH	Julia Soto has nothing to disclose.
Nicolas Dupre, MD, FAAN	Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.
Mustafa Jaffry	Mr. Jaffry has nothing to disclose.
Balasubramanian Samivel, MD	Dr. Samivel has nothing to disclose.
Alirexa Faridar, MD	Dr. Faridar has nothing to disclose.
Abdulhafeez Khair, MD	Dr. Khair has nothing to disclose.
David Rog, MBBS	Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Rog has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedDay. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen-Cilag. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. The institution of Dr. Rog has received research support from Actelion. The institution of Dr. Rog has received research support from Biogen. The institution of Dr. Rog has received research support from MedDay. The institution of Dr. Rog has received research support from Merck. The institution of Dr. Rog has received research support from Mitsubishi. The institution of Dr. Rog has received research support from Novartis. The institution of an immediate family member of Dr. Rog has received research support from Sanofi Genzyme. The institution of Dr. Rog has received research support from TG Therapeutics. Dr. Rog has received research support from Janssen-Cilag.
Lucio Tremolizzo	No disclosure on file
Thomas Finnegan, Jr., PhD	Dr. Finnegan has nothing to disclose.
Gerald A. Onwuegbuzie, MD	No disclosure on file
Francois Cadiou, MBA	Mr. Cadiou has received personal compensation for serving as an employee of Healint.
Lakshmi N. Ranganathan, MD, FAAN	Dr. Ranganathan has nothing to disclose.
Michael G. Dwyer III, MD, PhD	Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
Jon Riolo, PhD	Dr. Riolo has received personal compensation for serving as an employee of Bristol Myers Squib.
Robert B. Darnell, MD, PhD	Dr. Darnell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atreca, Inc.. Dr. Darnell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MITRE. Dr. Darnell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for OPNA.
Daniel Mandel, MD	Dr. Mandel has nothing to disclose.
Dileep R. Yavagal, MD, FAAN	Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vascular Dynamics. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. The institution of Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus/Johnson & Johnson. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Poseydon. Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Athersys. Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gravity Medical Technology. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseydon. Dr. Yavagal has stock in Poseydon. Dr. Yavagal has stock in Galaxy Therapeutics. Dr. Yavagal has stock in Stentrode. Dr. Yavagal has stock in Gravity Medical. Dr. Yavagal has stock in Gravity Medical Technology. Dr. Yavagal has stock in Athersys. Dr. Yavagal has stock in Rapid Medical . Dr. Yavagal has received intellectual property interests from a discovery or technology relating to health care. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Expert with Royal Carribean Cruise Line. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Consultant with Carnival Cruise Line.
Kaiz S. Asif, MD	Dr. Asif has nothing to disclose.
Sharon Hassin, MD	Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ABBVIE. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MEDISON. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NEURODERM. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA.
Dana Horakova	Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Lovingly Q. Park, PhD	Dr. Park has received personal compensation for serving as an employee of Supernus Pharmaceuticals.
Niels Bergsland	Prof. Bergsland has nothing to disclose.
Cemal Karakas, MD	Dr. Karakas has nothing to disclose.
Hannah Irvine, MD	Dr. Irvine has nothing to disclose.
Blair Cotton	Blair Cotton has nothing to disclose.
Elisa Canu	The institution of Elisa Canu has received research support from Italian Ministry of Health .
Daniel D. Truong, MD, FAAN	The institution of Dr. Truong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. The institution of Dr. Truong has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Truong has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. The institution of Dr. Truong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Truong has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Truong has received research support from Abbvie. The institution of Dr. Truong has received research support from Aeon. The institution of Dr. Truong has received research support from Biogen. The institution of Dr. Truong has received research support from Bukwang. The institution of Dr. Truong has received research support from Cerevel. The institution of Dr. Truong has received research support from Eli Lilly. The institution of Dr. Truong has received research support from Enterin. The institution of Dr. Truong has received research support from Ipsen. The institution of Dr. Truong has received research support from Lundbeck. The institution of Dr. Truong has received research support from Neurocrine. The institution of Dr. Truong has received research support from Neuroderm. The institution of Dr. Truong has received research support from Parkinson Foundation. The institution of Dr. Truong has received research support from Prilenia. The institution of Dr. Truong has received research support from Revance. The institution of Dr. Truong has received research support from Sunovion. Dr. Truong has received publishing royalties from a publication relating to health care. Dr. Truong has received publishing royalties from a publication relating to health care. Dr. Truong has a non-compensated relationship as a President with International Association for Parkinsonism and Related Disorders that is relevant to AAN interests or activities.
Nizar Souayah, MD, FAAN	Dr. Souayah has received publishing royalties from a publication relating to health care.
Melissa Assaf, NP, APN-Genetics	Dr. Assaf has nothing to disclose.
Kim I. Bishop, PhD	Dr. Bishop has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for zogenix. Dr. Bishop has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Medtronic. Dr. Bishop has stock in zogenix.
Maya N. Hatch, PhD	Maya Hatch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bioniks. Maya Hatch has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum. The institution of Maya Hatch has received research support from Fulcrum Therapeutics.
Navreet Kaur, MBBS	Dr. Kaur has nothing to disclose.
Gabrielle Macaron, MD	Dr. Macaron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Macaron has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Macaron has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Macaron has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD-Serono. Dr. Macaron has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Macaron has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Macaron has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MedEdge. Dr. Macaron has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Macaron has received research support from National MS Society/International Progressive Multiple Sclerosis Alliance .
Megan Leitch, MD	Dr. Leitch has nothing to disclose.
Alex Aimetti	No disclosure on file
Gregory N. Beatch, PhD	Dr. Beatch has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc. Dr. Beatch has stock in Xenon Pharmaceuticals Inc. Dr. Beatch has received intellectual property interests from a discovery or technology relating to health care.
Quentin Funk	No disclosure on file
Kathleen Bradbury	Ms. Bradbury has nothing to disclose.
Fawaz Al-Mufti, MD	Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Revalesio .
Peter Alabi, Sr., MBBS, FMCP	Dr. Alabi has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Norvatis.
Namita Tundia, PhD	Mrs. Tundia has received personal compensation for serving as an employee of EMD Serono.
Constanza Luzon	Constanza Luzon has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Constanza Luzon has stock in Xenon Pharmaceuticals.
Deborah I. Friedman, MD, MPH, FAAN	Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Friedman has received personal compensation in the range of $0-$499 for serving as a Consultant for Satsuma. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Reviews. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology . The institution of Dr. Friedman has received research support from Spinal CSF Leak Foundation. Dr. Friedman has a non-compensated relationship as a Program Co-Chair, Scottsdale Headache Symposium with American Headache Society that is relevant to AAN interests or activities. Dr. Friedman has a non-compensated relationship as a Medical Advisor with Spinal CSF Leak Foundation that is relevant to AAN interests or activities. Dr. Friedman has a non-compensated relationship as a Treasurer, Board of Directors with Southern Headache Society that is relevant to AAN interests or activities.
Clara Thiel, MD	Dr. Thiel has nothing to disclose.
Ali Mohajer, PhD	Dr. Mohajer has received personal compensation for serving as an employee of Qral Group, LLC.
Krithi Irmady, MD, MBBS	An immediate family member of Dr. Irmady has received personal compensation in the range of $0-$499 for serving as a Consultant for Adivo Associates LLC. An immediate family member of Dr. Irmady has stock in Doximity. The institution of Dr. Irmady has received research support from William N and Bernice E Bumpus Foundation. The institution of Dr. Irmady has received research support from American Academy of Neurology. An immediate family member of Dr. Irmady has received personal compensation in the range of $5,000-$9,999 for serving as a Reviewer with Cancer Prevention and Research Institute Texas(CPRIT). Dr. Irmady has received personal compensation in the range of $0-$499 for serving as a Reviewer with Luxembourg National Research fund . An immediate family member of Dr. Irmady has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with Memorial Sloan Kettering Cancer Center.
E M. Bebin, MD, FAAN	Dr. Bebin has received personal compensation for serving as an employee of Springworks Therapeutics. Dr. Bebin has received personal compensation for serving as an employee of Apertura Gene Therapy. Dr. Bebin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks Therapeutics. Dr. Bebin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apertura. The institution of Dr. Bebin has received research support from NINDS. The institution of Dr. Bebin has received research support from FDA Orphan Drug Program.
Eric Klawiter, MD, FAAN	Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Galen/Atlantica. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Banner Life Sciences. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Klawiter has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for OM1. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Klawiter has received research support from Biogen. The institution of Dr. Klawiter has received research support from Abbvie. The institution of Dr. Klawiter has received research support from Genentech.
Jens Kuhle, MD	Dr. Kuhle has nothing to disclose.
L M. Frank, MD	Dr. Frank has received stock or an ownership interest from ReAlta Life Sciences.
Kiana Moussavi, MD	Ms. Moussavi has nothing to disclose.
Tiffany Ward, MD	Dr. Ward has nothing to disclose.
Paula Barreras, MD	The institution of Dr. Barreras has received research support from Foundation for Sarcoidosis Research. The institution of Dr. Barreras has received research support from American Academy of Neurology.
Tomas Kalincik	Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Health and Medical Research Council. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MS Research Australia. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for WebMD Global. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for BioCSL. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Tomas Kalincik has received research support from Biogen. The institution of Tomas Kalincik has received research support from Novartis. The institution of Tomas Kalincik has received research support from Genzyme. The institution of Tomas Kalincik has received research support from Roche. The institution of Tomas Kalincik has received research support from Celgene. The institution of Tomas Kalincik has received research support from Merck. The institution of Tomas Kalincik has received research support from MSBase Foundation. The institution of Tomas Kalincik has received research support from ARSEP and EDMUS Foundations. The institution of Tomas Kalincik has received research support from MS Research Australia. The institution of Tomas Kalincik has received research support from National Health and Medical Research Council. The institution of Tomas Kalincik has received research support from Australian Research Council. The institution of Tomas Kalincik has received research support from MS Society. The institution of Tomas Kalincik has received research support from Trish Foundation. Tomas Kalincik has a non-compensated relationship as a scientific leadership group vice-chair with MSBase Foundation that is relevant to AAN interests or activities.
Arnold Gammaitoni, PharmD	Dr. Gammaitoni has received personal compensation for serving as an employee of Zogenix Inc.. Dr. Gammaitoni has received stock or an ownership interest from Zogenix Inc..
Neil S. Graham, MD	The institution of Dr. Graham has received research support from UK National Institute for Health Research. The institution of Dr. Graham has received research support from Alzheimer's Research UK.
Henrik Zetterberg	No disclosure on file
Jose Luis Sanchez Menoyo, MD	Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Alise K. Carlson, MD	Dr. Carlson has received research support from Biogen (fellowship grant 16696-P-FEL).
Lindsey M. Ladd, DO	Dr. Ladd has nothing to disclose.
Joseph Hulihan, Jr., MD	Dr. Hulihan has received personal compensation for serving as an employee of MARINUS PHARMACEUTICALS. Dr. Hulihan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ZYNERBA PHARMACEUTICALS.
Jaroslaw Slawek, MD	No disclosure on file
Krutika Jariwala-Parikh, PhD	Dr. Jariwala-Parikh has received personal compensation for serving as an employee of AbbVie. Dr. Jariwala-Parikh has stock in AbbVie.
Elisabetta Verdun Di Cantogno, MD	Dr. Verdun Di Cantogno has received personal compensation for serving as an employee of EMD Serono Research & Development Institute, Inc., Billerica, MA, USA. Dr. Verdun Di Cantogno has stock in EMD Serono Research & Development Institute, Inc., Billerica, MA, USA.
Paolo Preziosa	Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Sukriye Damla Kara, MD	Dr. Kara has nothing to disclose.